Logos Global Management as of March 31, 2026
Portfolio Holdings for Logos Global Management
Logos Global Management holds 63 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 9.7 | $195M | 2.0M | 97.25 | |
| Erasca (ERAS) | 9.0 | $180M | 11M | 16.18 | |
| Ideaya Biosciences (IDYA) | 5.7 | $115M | 3.5M | 33.32 | |
| Terns Pharmaceuticals (TERN) | 5.3 | $105M | 2.0M | 52.72 | |
| Praxis Precision Medicines I Com New (PRAX) | 4.6 | $92M | 285k | 322.19 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 4.2 | $84M | 2.1M | 39.72 | |
| Abivax Sa Sponsored Ads (ABVX) | 3.8 | $75M | 675k | 111.35 | |
| Tango Therapeutics (TNGX) | 3.1 | $63M | 3.0M | 20.92 | |
| Cytokinetics Com New (CYTK) | 2.9 | $58M | 875k | 65.91 | |
| Olema Pharmaceuticals (OLMA) | 2.4 | $48M | 3.2M | 14.91 | |
| United Therapeutics Corporation (UTHR) | 2.4 | $47M | 80k | 592.98 | |
| Immunocore Hldgs Ads (IMCR) | 2.3 | $45M | 1.5M | 30.15 | |
| Madrigal Pharmaceuticals (MDGL) | 2.2 | $45M | 85k | 523.47 | |
| Enliven Therapeutics (ELVN) | 2.0 | $41M | 1.0M | 39.20 | |
| Rhythm Pharmaceuticals (RYTM) | 2.0 | $39M | 450k | 86.97 | |
| Cg Oncology (CGON) | 1.9 | $39M | 575k | 67.68 | |
| Maze Therapeatics (MAZE) | 1.8 | $37M | 1.2M | 29.85 | |
| Biogen Idec (BIIB) | 1.8 | $37M | 200k | 183.33 | |
| Disc Medicine (IRON) | 1.8 | $36M | 560k | 63.94 | |
| Dianthus Therapeutics (DNTH) | 1.7 | $34M | 400k | 83.92 | |
| Ocular Therapeutix (OCUL) | 1.6 | $33M | 3.9M | 8.47 | |
| Tyra Biosciences (TYRA) | 1.6 | $33M | 850k | 38.30 | |
| Trevi Therapeutics (TRVI) | 1.4 | $29M | 2.4M | 11.93 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.4 | $28M | 1.5M | 18.64 | |
| Immunovant (IMVT) | 1.3 | $27M | 1.1M | 24.84 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $26M | 450k | 58.15 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $26M | 1.2M | 21.60 | |
| Dyne Therapeutics (DYN) | 1.3 | $25M | 1.4M | 18.13 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.2 | $24M | 500k | 48.20 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 1.1 | $23M | 915k | 24.66 | |
| Design Therapeutics (DSGN) | 1.0 | $21M | 2.0M | 10.64 | |
| Avalo Therapeutics Com New (AVTX) | 1.0 | $19M | 1.3M | 14.93 | |
| Minerva Neurosciences Com New (NERV) | 1.0 | $19M | 3.2M | 6.03 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.0 | $19M | 600k | 32.01 | |
| Mirum Pharmaceuticals (MIRM) | 0.9 | $19M | 200k | 92.38 | |
| Vaxcyte (PCVX) | 0.9 | $17M | 300k | 58.11 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $17M | 750k | 22.26 | |
| Compass Therapeutics (CMPX) | 0.8 | $17M | 3.2M | 5.29 | |
| Celldex Therapeutics Com New (CLDX) | 0.7 | $14M | 450k | 31.72 | |
| Janux Therapeutics (JANX) | 0.7 | $14M | 1.0M | 13.90 | |
| Vor Biopharma Com New (VOR) | 0.7 | $13M | 750k | 17.84 | |
| Alkermes SHS (ALKS) | 0.6 | $12M | 350k | 35.36 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $12M | 950k | 12.67 | |
| Immix Biopharma (IMMX) | 0.6 | $11M | 1.2M | 9.11 | |
| Tenax Therapeutics Com New (TENX) | 0.5 | $10M | 625k | 15.99 | |
| Amylyx Pharmaceuticals (AMLX) | 0.5 | $9.7M | 700k | 13.90 | |
| Crescent Biopharma (CBIO) | 0.4 | $8.9M | 483k | 18.37 | |
| Soleno Therapeutics (SLNO) | 0.4 | $8.4M | 250k | 33.48 | |
| Arrivent Biopharma (AVBP) | 0.4 | $8.1M | 350k | 23.07 | |
| Relay Therapeutics (RLAY) | 0.4 | $7.5M | 750k | 9.95 | |
| Corvus Pharmaceuticals (CRVS) | 0.3 | $6.6M | 450k | 14.63 | |
| Meiragtx Holdings (MGTX) | 0.3 | $6.1M | 700k | 8.66 | |
| Jade Biosciences Com New (JBIO) | 0.3 | $5.6M | 400k | 14.05 | |
| Verastem Com New (VSTM) | 0.3 | $5.3M | 1.0M | 5.30 | |
| Unicycive Therapeutics Com New (UNCY) | 0.2 | $3.1M | 474k | 6.58 | |
| Ibio Com New (IBIO) | 0.1 | $2.5M | 1.3M | 1.90 | |
| Palatin Technologies Com New (PTN) | 0.1 | $2.4M | 140k | 17.42 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $1.9M | 500k | 3.75 | |
| Pharvaris N V (PHVS) | 0.1 | $1.8M | 65k | 28.25 | |
| Veradermics Common Stock | 0.1 | $1.6M | 25k | 63.15 | |
| Sensei Biotherapeutics Com New (SNSE) | 0.0 | $946k | 30k | 31.52 | |
| Septerna (SEPN) | 0.0 | $566k | 24k | 24.03 | |
| Fractyl Health (GUTS) | 0.0 | $458k | 1.0M | 0.46 |